Skip to main content

and
  1. Article

    Open Access

    A case report of psychiatric symptoms following direct-acting antiviral and ribavirin combination therapy for chronic hepatitis C in a patient with innate anxiety

    Direct-acting antivirals (DAAs) result in a highly sustained virological response rate and better patient tolerance. However, this therapeutic approach may, on rare occasions, give rise to psychiatric symptoms...

    Akira Sakamaki, Kenya Kamimura, Naoki Fukui, Haruka Watanabe in BMC Gastroenterology (2019)

  2. No Access

    Article

    Early injection of human adipose tissue-derived mesenchymal stem cell after inflammation ameliorates dextran sulfate sodium-induced colitis in mice through the induction of M2 macrophages and regulatory T cells

    Inflammatory bowel diseases (IBDs) are sometimes refractory to current therapy or associated with severe adverse events during immunosuppressive therapy; thus, new therapies are urgently needed. Recently, mese...

    Yuzo Kawata, Atsunori Tsuchiya, Satoshi Seino, Yusuke Watanabe in Cell and Tissue Research (2019)

  3. Article

    Open Access

    POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33

    Primary biliary cholangitis (PBC) is a chronic and cholestatic autoimmune liver disease caused by the destruction of intrahepatic small bile ducts. Our previous genome-wide association study (GWAS) identified ...

    Yuki Hitomi, Kazuko Ueno, Yosuke Kawai, Nao Nishida, Kaname Kojima in Scientific Reports (2019)

  4. Article

    Open Access

    Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis

    Although patients with primary biliary cholangitis (PBC) experience a variety of symptoms that could impair health-related quality of life (HRQOL), no studies regarding symptoms and impact of PBC on HRQOL have...

    Minami Yagi, Atsushi Tanaka, Masanori Abe, Tadashi Namisaki in Scientific Reports (2018)

  5. Article

    Open Access

    Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies

    The impact of sarcopenia on the prognosis of patients with hepatocellular carcinoma (HCC) who receive transcatheter intra-arterial therapies, including transcatheter arterial chemoembolization and transcathete...

    Takamasa Kobayashi, Hirokazu Kawai, Oki Nakano, Satoshi Abe in BMC Cancer (2018)

  6. Article

    Open Access

    Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma

    Cell motility plays an important role in intrahepatic metastasis of hepatocellular carcinoma (HCC), and predicts poor prognosis in patients. The present study investigated the role of a disintegrin and metallo...

    Hiroki Honda, Masaaki Takamura, Satoshi Yamagiwa, Takuya Genda in Scientific Reports (2017)

  7. Article

    Open Access

    Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient

    A 56-year-old Japanese man with liver cirrhosis (LC) due to hepatitis C virus was admitted to our hospital for radiofrequency ablation of residual tumor following lusutrombopag administration. Laboratory tests...

    Akira Sakamaki, Takayuki Watanabe, Satoshi Abe in Clinical Journal of Gastroenterology (2017)

  8. Article

    Open Access

    Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial

    Based on promising results from a Phase I study of hepatic arterial infusion chemotherapy using a combination of miriplatin and cisplatin powder (DDP-H) for unresectable hepatocellular carcinoma (UMIN-CTR00000...

    Kenya Kamimura, Takeshi Suda, Takeshi Yokoo, Hiroteru Kamimura in BMC Cancer (2017)

  9. No Access

    Article

    First case of bacteremia caused by Helicobacter cinaedi in a patient with liver cirrhosis: a case report and literature review

    Patients with liver cirrhosis are known to be immunocompromised hosts due to the dysfunction of the cellular and humoral immune systems, allowing easier bacterial translocation from the intestine to the system...

    Kenya Kamimura, Daisuke Kumaki, Masashi Arita in Clinical Journal of Gastroenterology (2015)

  10. No Access

    Article

    Value of shear wave velocity measurements for the risk assessment of hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease

    To evaluate the value of measuring shear wave velocity evoked by acoustic radiation force impulse (VTTQ) for the risk assessment of hepatocellular carcinoma (HCC) development in patients with nonalcoholic fatt...

    Masaaki Takamura, Tsutomu Kanefuji, Takeshi Suda, Takeshi Yokoo in Hepatology International (2014)

  11. No Access

    Article

    Clinical significance of cell cycle inhibitors in hepatocellular carcinoma

    It is well accepted that cell cycle regulators are strongly implicated in the progression of cancer development. p16 and p27 are potent cyclin-dependent kinase (CDK) inhibitors involved in G1 phase progression...

    Yasunobu Matsuda, Toshifumi Wakai, Masayuki Kubota in Medical Molecular Morphology (2013)

  12. No Access

    Article

    Involvement of liver-intestine cadherin in cancer progression

    Cadherins constitute a superfamily of Ca2+-dependent cell adhesion molecules that play critical roles in the maintenance of tissue structure and morphogenesis. Their dysregulation is commonly observed in a variet...

    Masaaki Takamura, Satoshi Yamagiwa, Yasunobu Matsuda in Medical Molecular Morphology (2013)

  13. No Access

    Article

    Increased Susceptibility to Severe Chronic Liver Damage in CXCR4 Conditional Knock-Out Mice

    The chemokine SDF-1 and its receptor CXCR4 are essential for the proper functioning of multiple organs. In the liver, cholangiocytes and hepatic progenitor cells (HPCs) are the main cells that produce SDF-1, a...

    Atsunori Tsuchiya, Michitaka Imai, Hiroteru Kamimura in Digestive Diseases and Sciences (2012)

  14. Article

    Open Access

    Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma

    There is no standard therapeutic procedure for the hepatocellular carcinoma (HCC) in patients with poor hepatic reserve function. With the approval of newly developed chemotherapeutic agent of miriplatin, we h...

    Kenya Kamimura, Takeshi Suda, Yasushi Tamura, Masaaki Takamura in BMC Gastroenterology (2012)

  15. No Access

    Article

    Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

    The association between serum alpha-fetoprotein (AFP) levels during and after interferon (IFN) therapy and the development of hepatocellular carcinoma (HCC) was evaluated in patients with chronic hepatitis C (...

    Yasushi Tamura, Satoshi Yamagiwa, Yohei Aoki, So Kurita in Digestive Diseases and Sciences (2009)

  16. No Access

    Article

    Natural killer cell receptors and their ligands in liver diseases

    The liver is a distinctive immune organ with predominant innate immunity, being rich in innate immune cells such as natural killer (NK) cells. In humans, NK cells comprise about 30%–50% of intrahepatic lymphoc...

    Satoshi Yamagiwa, Hiroteru Kamimura, Takafumi Ichida in Medical Molecular Morphology (2009)

  17. Article

    Open Access

    Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type B

    To study the changes in serum ferritin levels in lamivudine (LAM)-treated patients with chronic hepatitis and liver cirrhosis type B and determine whether successful treatment with LAM results in a reduction o...

    Shogo Ohkoshi, Akira Yoshimura, Satoshi Yamamoto, Masahiko Yano in Hepatology International (2008)

  18. No Access

    Chapter and Conference Paper

    Clinical Significance of Liposome-Encapsulated OK-432 Injection with Simultaneous Interventional Radiological Treatment of Hepatocellular Carcinoma Based on Experimental Analysis of Liver-Associated Lymphocytes

    OK-432 is a biological response modifier used in Japan to augment host immunity and is known to increase the host antitumor response. Using liposomes, which are vesicles made of phospholipids that have a struc...

    Takafumi Ichida, Satoshi Yamagiwa in Progress in Hepatocellular Carcinoma Treat… (2000)